A simple cryopreservation method for dendritic cells and cells used in their derivation and functional assessment

Transfusion

Volumn 43, Issue 4, 2003, Pages 488-494

  Celluzzi, Christina M ^a,b   Welbon, Craig ^a  

^a AMERICAN RED CROSS   (United States)

^b HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; DIMETHYL SULFOXIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HETASTARCH; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APHERESIS; ARTICLE; CELL CULTURE; CELL MATURATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; DENDRITE; FREEZING; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; LYMPHOCYTE; MIXED LYMPHOCYTE REACTION; MONOCYTE; MONONUCLEAR CELL; PERIPHERAL CIRCULATION; PHENOTYPE; STEM CELL; STORAGE;

ANTIGENS, CD14; ANTIGENS, CD3; BLOOD COMPONENT REMOVAL; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; CULTURE MEDIA, SERUM-FREE; DENDRITIC CELLS; DIMETHYL SULFOXIDE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEAT; HETASTARCH; HUMANS; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MONOCYTES; SERUM ALBUMIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037387237     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00359.x     Document Type: Article

References (23)

1. Banchereau J. Dendritic cells: therapeutic potentials. Transfus Sci 1997;18:313-26.
2. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
3. Celluzzi CM, Mayordomo JI, Storkus WJ, et al. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 1996; 183:283-7.
4. Tjoa BA, Simmons SJ, Bowes VA, et al. Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. Prostate 1998;36:39-44.
5. Hsu FJ, Benike C, Fagnoni F. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1999;2:52-8.
6. Kugler A, Stuhler G, Walden P, et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med 2000;6:332-6.
7. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
8. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-18.
9. Thurner B, Haendle I, Roder C, et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999;190:1669-78.
10. Thurner B, Roder C, Dieckmann D, et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Meth 1999;223:1-15.
11. Gong J, Chen D, Kashiwaba M, et al. Induction of antitumor activity by immunization with fusions of dendritic cells and carcinoma cells. Nat Med 1997;3:558-61.
12. Feuerstein B, Berger TG, Maczek C, et al. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J Immunol Meth 2000;245:15-29.
13. Lewallel P, Rouas R, Lehmann F, Martiat P. Freezing of dendritic cells, generated from cryopreserved leukaphereses, does not influence their ability to induce antigen-specific immune responses or functionally react to maturation stimuli. J Immunol Meth 2000;240:69-78.
14. Stiff PJ, Koester AR, Eagleton LE, et al. Autologous stem cell transplantation using peripheral blood stem cells. Transplantation 1987;44:585-8.
15. Stiff PJ, Koester AR, Weidner MK, et al. Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 1987;70:974-8.
16. Halle P, Tournilhac O, Knopinska-Posluszny W, et al. Uncontrolled-rate freezing and storage at - 80 degrees C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001;41:667-73.
17. Harada M, Taniguchi S, Teshima T, et al. Cryopreservation, cytokine mobilization, and autotransplantation of peripheral blood stem cells. Prog Clin Biol Res 1992;377:297-308.
18. Makino S, Harada M, Akashi K, et al. A simplified method for cryopreservation of peripheral blood stem cells at - 80 degrees C without rate-controlled freezing. Bone Marrow Transplant 1991;8:239-44.
19. Lionetti FJ, Hunt SM, Mattaliano RJ, et al. In vitro studies cryopreserved baboon granulocytes. Transfusion 1978;18:685-92.
20. Skubitz KM, Pessano S, Bottero L, et al. Human granulocyte surface molecules identified by murine monoclonal antibodies. J Immunol 1983;131:1882-8.
21. Noraz N, Lathey JL, Spector SA. Human cytomegalovirus-associated immunosuppression is mediated through interferon-alpha. Blood 1997;89:2443-52.
22. Steinkamp JA, Wilson JS, Saunders GC, et al. Phagocytosis: flow cytometric quantitation with fluorescent microspheres. Science 1982;215:64-6.
23. Hunt SM, Lionetti FJ, Valeri CR, et al. Cryogenic preservation of monocytes from human blood and plateletpheresis cellular residues. Blood 1981;57:592-8.